Gastric cancer
Conditions
Interventions
Supplementation of Uplead
Sponsors
Kanagawa Cancer Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: i. Histologically proven adenocarcinoma of the stomach ii.Clinical T1-T4a and no distant metastasis iii.R0 resection is possible by open total gastrectomy iv.Enough oral intake after sugery v.Age ranging between 20 and more. vi.ECOG performance status 0-1. vii.Not cancer of the remnant stomach viii.Suficient organ functions. iv.Written informed consent.
Exclusion criteria
Exclusion criteria: i.Synchronous or metachronous cancer (synchronous multiple cancers in the stomach included). ii.Active inflammation which requires systemic treatment iii.Allergy for contents of Uplead iv.Uncontrollable diabetes mellitus v.Systemic treatment with corticosteroid vi.Unstable angina or cardiac infarction within 6 months vii.Pulmonary disorder under oxygen viii.Woman with on-going pregnancy or breast-feeding, or contemplating pregnancy. ix.Mental disorders which may affect ability or willingness to provide informed consent or abide by the study protocol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| compliance with supplementation | — |
Secondary
| Measure | Time frame |
|---|---|
| body weight and lean body mass reduction 1 month and 3 months after surgery | — |
Countries
Japan
Contacts
Public ContactTakanobu Yamada
Kanagawa Cancer Center Department of Gastrointestinal Surgery
Outcome results
None listed